News

Latest industry coverage

All India World

Most watched

Google News

The Pharma Letter

Danish industry warns against state-built production of critical meds

Packaging Gateway

Faller to acquire Greek pharma packaging business Paperpack

Air Cargo Week

IAG expands pharma network with Kuala Lumpur constant climate station

The Pharma Letter

AstraZeneca discontinues eVOLVE-Lung02 Phase III trial

business-live.co.uk

Newcastle biotech pioneers BSF aim for robotics and luxury cars in strategic deal

PharmaShots

Aug 17, 2026, 10:30 AM

HUTCHMED Reports P-III (SAFFRON) Trial Data on Orpathys + Tagrisso for MET-Driven EGFRm Lung Cancer

Shots: Ref: Businesswire | Image: HUTCHMED | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post HUTCHMED Reports P-III (SAFFRON) Trial Data on Orpathys + Tagrisso for MET-Driven EGFRm Lung Cancer appeared first on PharmaShots.

Pharma Tech

Aug 17, 2026, 9:20 AM

EMA validates Pfizer and Valneva’s Lyme disease vaccine

The EMA has validated the MAA from Pfizer and Valneva for their Lyme disease vaccine candidate, PF-07307405.